HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A boy with acute lymphoblastic leukemia acquired clonal and nonclonal cytogenetic abnormalities including del(7q) and del(20q) without clinical evidence of disease after sex-mismatched cord blood transplantation.

Abstract
An 8-year-old boy was diagnosed with precursor B-cell acute lymphoblastic leukemia. After intensified chemotherapy, he underwent sex-mismatched allogeneic cord blood transplantation. Postcord blood transplantation cytogenetic studies revealed engraftment failure evidenced by switching into the recipient type (XY), and, notably, various complex chromosomal aberrations in the recipient cells. Nonclonal and clonal aberrations including deletions of 7q and 20q were persistently observed. Nonetheless, the patient was clinically stable without evidence of marrow dysplasia or leukemic cells. Del(7q) and del(20q), 2 recurrent chromosomal aberrations in myeloid neoplasia, might represent underlying genomic instability in this patient, not the direct culprits of dysplasia or leukemogenesis.
AuthorsIn-Suk Kim, Hee-Jin Kim, Keon-Hee Yoo, Ki-Woong Sung, Sun-Hee Kim
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 28 Issue 8 Pg. 540-3 (Aug 2006) ISSN: 1077-4114 [Print] United States
PMID16912597 (Publication Type: Case Reports, Journal Article)
Topics
  • Blood Group Incompatibility (pathology)
  • Burkitt Lymphoma (genetics)
  • Child
  • Chromosome Aberrations
  • Chromosome Deletion
  • Chromosomes, Human, Pair 20 (genetics)
  • Chromosomes, Human, Pair 7 (genetics)
  • Cord Blood Stem Cell Transplantation (adverse effects)
  • Histocompatibility Testing (methods)
  • Humans
  • Male
  • Remission Induction
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed (methods)
  • Transplantation Conditioning (methods)
  • Transplantation, Homologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: